Login to Your Account



MAT BioPharma Plans Phase III Trial, Negotiates EUR12M Funding

By James Etheridge


Wednesday, May 3, 2006
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription